Insider at

04

Insider transactions

05
0 buys (P) 0 sells (S) Net: $0 + 1 non-open-market transaction below last 12 months, based on the transactions shown below

Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted

No open-market trades on record; showing all filings.

DateTickerCodeSharesPriceValue Owned afterΔ ownA/Dvs now
Feb. 1, 2023 AEMD A 60,620 · · 60,620 Direct · Acquired (price as of 2026-10-02)

P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding

Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.

Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.

06
DateTickerSecurityUnderlying Exercise priceExpirationSharesA/D
Feb. 1, 2023 AEMD Employee Stock Option (Right to Buy) Common Stock (60,620) $0.69 Jan. 31, 2033 60,620 Acquired

Exercise/conversion price is blank when not applicable (e.g. RSUs).

Initial ownership (Form 3) 3 holdings

07

Securities held when first becoming an insider, per SEC Form 3.

DateTickerSecuritySharesOwnership
April 15, 2015 ASMB Stock Option (right to buy)→ Common Stock, $0.001 par value per share · Direct
July 15, 2014 ASMB Stock Option (right to buy)→ Common Stock, $0.001 par value per share · Direct
July 14, 2014 ASMB Stock Option (right to buy)→ Common Stock, $0.001 par value per share · Direct

Compensation (DEF 14A)

08

Matched by name from proxy statements (DEF 14A) — verify against the filing.

ASMB

M.D.Chief Scientific Officer
Fiscal yearSalaryBonusStock awards Option awardsNon-equity incentivePension changeOtherTotal
2015 $315,000 · · · $85,050 · $81,953 $482,003
2014 $144,375 · · · $51,188 · · $195,563
2013 · · · · · · · ·

Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.